Clinical Trial Update: IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation

View source ↗

Summary

A ClinicalTrials.gov update indicates that the IIT-2022-Simultaneous Urolift and Median Lobe Enucleation trial for benign prostatic hyperplasia sponsored by the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• UroLift System

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Benign Prostatic Hyperplasia | Status: TERMINATED